肝细胞癌:信号通路和治疗进展
Jiaojiao Zheng1, Siying Wang1, Lei Xia2
1State Key Laboratory of Systems Medicine for Cancer, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, PR China.
肝癌,主要是肝细胞癌 (HCC),是全球日益严重的健康问题. 对信号通路和向治疗的研究为改善HCC管理和治疗结果提供了希望.
科学领域:
- 肝病学和瘤学 肝病学和瘤学
- 分子生物学分子生物学
- 癌症治疗方法 癌症治疗方法
背景情况:
- 肝癌,特别是肝细胞癌 (HCC),是一个重大的全球健康挑战,发病率不断增加.
- 早期的HCC往往缺乏症状,导致晚期诊断和晚期,无法治愈的疾病.
- 失调的信号通路驱动HCC的进展,转移和复发.
研究的目的:
- 提供有关HCC.涉及的细胞信号通路的全面审查.
- 探索针对这些途径及其抑制剂的治疗潜力.
- 讨论临床试验证据和HCC治疗的未来方向.
主要方法:
- 对HCC信号通路的当前文献的综述.
- 对临床试验后期阶段证据的分析.
- 在早期临床试验和生物标志物识别中讨论概念.
主要成果:
- 确定了关键信号通路 (RTK,分化,端粒,表观遗传,应激反应),在HCC中具有治疗潜力.
- 总结了当前先进的HCC治疗方法,包括氨酸激酶抑制剂 (TKI) 和免疫检查点抑制剂 (ICI).
- 突出显示正在进行的试验,结合ICI,TKI和抗VEGF疗法.
结论:
- 针对特定的信号通路对于推进HCC治疗至关重要.
- 组合疗法显示出对所有阶段的HCC管理进行革命性的承诺.
- 对生物标志物和新疗法的进一步研究对于有效控制HCC至关重要.
更多相关视频
12:24A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
Published on: September 30, 2021
11:08Advances in Human Induced Pluripotent Stem Cell-Derived Chimeric Antigen Receptor-Expressing Natural Killer Cells
Published on: February 14, 2025
相关概念视频
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Hedgehog Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Signal Transduction: Overview
Typically, signal transduction involves three...
Canonical Wnt Signaling Pathway
